Cargando…

Augmented thrombin formation is related to circulating levels of extracellular vesicles exposing tissue factor and citrullinated histone-3 in anti-neutrophil cytoplasmic antibody-associated vasculitides

OBJECTIVES: To study circulating myeloperoxidase (MPO)-positive extracellular vesicles (MPO(+)EVs) exposing citrullinated histone-3 (H3Cit), tissue factor (TF), and plasminogen (Plg) in association to thrombin generation in patients with anti-neutrophil cytoplasm antibody (ANCA)-associated vasculiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Jonasdottir, Asta Dogg, Manojlovic, Milena, Vojinovic, Jelena, Nordin, Annica, Bruchfeld, Annette, Gunnarsson, Iva, Mobarrez, Fariborz, Antovic, Aleksandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616855/
https://www.ncbi.nlm.nih.gov/pubmed/37915326
http://dx.doi.org/10.3389/fmed.2023.1240325
_version_ 1785129485220184064
author Jonasdottir, Asta Dogg
Manojlovic, Milena
Vojinovic, Jelena
Nordin, Annica
Bruchfeld, Annette
Gunnarsson, Iva
Mobarrez, Fariborz
Antovic, Aleksandra
author_facet Jonasdottir, Asta Dogg
Manojlovic, Milena
Vojinovic, Jelena
Nordin, Annica
Bruchfeld, Annette
Gunnarsson, Iva
Mobarrez, Fariborz
Antovic, Aleksandra
author_sort Jonasdottir, Asta Dogg
collection PubMed
description OBJECTIVES: To study circulating myeloperoxidase (MPO)-positive extracellular vesicles (MPO(+)EVs) exposing citrullinated histone-3 (H3Cit), tissue factor (TF), and plasminogen (Plg) in association to thrombin generation in patients with anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV). METHODS: We have involved well-characterized patients with AAV together with population-based controls. Flow cytometry was used to assess the levels of MPO(+)EVs in citrated plasma. MPO(+)EVs were phenotyped by anti-MPO-antibodies together with anti-CD142 (anti-TF), anti-H3Cit, and anti-Plg antibodies. A modified Calibrated Automated Thrombogram (CAT) assay was utilized to measure thrombin generation in plasma initiated by EVs-enriched pellets. The activity of AAV was evaluated with the Birmingham Vasculitis Activity Score (BVAS). RESULTS: This study comprised 46 AAV patients, 23 in the active stage of the disease and 23 in remission, as well as 23 age- and sex matched population-based controls. Augmented levels of all investigated MPO(+) EVs were found in active AAV patients in comparison to the subgroup of patients in remission and controls. Thrombin generation, measured by endogenous thrombin potential (ETP) and peak of thrombin formation, was higher in plasma when triggered by EVs-enriched pellet from AAV patients. ETP and peak were associated with the levels of MPO(+)TF(+) and MPO(+)H3Cit(+) EVs. Additionally, MPO(+)TF(+) EVs correlated with the disease activity evaluated with BVAS. CONCLUSION: Augmented thrombin generation is found in AAV patients regardless of disease activity and is associated with higher exposure of TF and H3Cit on MPO(+)EVs. This may contribute to the increased risk of thrombosis seen in AAV patients.
format Online
Article
Text
id pubmed-10616855
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106168552023-11-01 Augmented thrombin formation is related to circulating levels of extracellular vesicles exposing tissue factor and citrullinated histone-3 in anti-neutrophil cytoplasmic antibody-associated vasculitides Jonasdottir, Asta Dogg Manojlovic, Milena Vojinovic, Jelena Nordin, Annica Bruchfeld, Annette Gunnarsson, Iva Mobarrez, Fariborz Antovic, Aleksandra Front Med (Lausanne) Medicine OBJECTIVES: To study circulating myeloperoxidase (MPO)-positive extracellular vesicles (MPO(+)EVs) exposing citrullinated histone-3 (H3Cit), tissue factor (TF), and plasminogen (Plg) in association to thrombin generation in patients with anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV). METHODS: We have involved well-characterized patients with AAV together with population-based controls. Flow cytometry was used to assess the levels of MPO(+)EVs in citrated plasma. MPO(+)EVs were phenotyped by anti-MPO-antibodies together with anti-CD142 (anti-TF), anti-H3Cit, and anti-Plg antibodies. A modified Calibrated Automated Thrombogram (CAT) assay was utilized to measure thrombin generation in plasma initiated by EVs-enriched pellets. The activity of AAV was evaluated with the Birmingham Vasculitis Activity Score (BVAS). RESULTS: This study comprised 46 AAV patients, 23 in the active stage of the disease and 23 in remission, as well as 23 age- and sex matched population-based controls. Augmented levels of all investigated MPO(+) EVs were found in active AAV patients in comparison to the subgroup of patients in remission and controls. Thrombin generation, measured by endogenous thrombin potential (ETP) and peak of thrombin formation, was higher in plasma when triggered by EVs-enriched pellet from AAV patients. ETP and peak were associated with the levels of MPO(+)TF(+) and MPO(+)H3Cit(+) EVs. Additionally, MPO(+)TF(+) EVs correlated with the disease activity evaluated with BVAS. CONCLUSION: Augmented thrombin generation is found in AAV patients regardless of disease activity and is associated with higher exposure of TF and H3Cit on MPO(+)EVs. This may contribute to the increased risk of thrombosis seen in AAV patients. Frontiers Media S.A. 2023-10-17 /pmc/articles/PMC10616855/ /pubmed/37915326 http://dx.doi.org/10.3389/fmed.2023.1240325 Text en Copyright © 2023 Jonasdottir, Manojlovic, Vojinovic, Nordin, Bruchfeld, Gunnarsson, Mobarrez and Antovic. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Jonasdottir, Asta Dogg
Manojlovic, Milena
Vojinovic, Jelena
Nordin, Annica
Bruchfeld, Annette
Gunnarsson, Iva
Mobarrez, Fariborz
Antovic, Aleksandra
Augmented thrombin formation is related to circulating levels of extracellular vesicles exposing tissue factor and citrullinated histone-3 in anti-neutrophil cytoplasmic antibody-associated vasculitides
title Augmented thrombin formation is related to circulating levels of extracellular vesicles exposing tissue factor and citrullinated histone-3 in anti-neutrophil cytoplasmic antibody-associated vasculitides
title_full Augmented thrombin formation is related to circulating levels of extracellular vesicles exposing tissue factor and citrullinated histone-3 in anti-neutrophil cytoplasmic antibody-associated vasculitides
title_fullStr Augmented thrombin formation is related to circulating levels of extracellular vesicles exposing tissue factor and citrullinated histone-3 in anti-neutrophil cytoplasmic antibody-associated vasculitides
title_full_unstemmed Augmented thrombin formation is related to circulating levels of extracellular vesicles exposing tissue factor and citrullinated histone-3 in anti-neutrophil cytoplasmic antibody-associated vasculitides
title_short Augmented thrombin formation is related to circulating levels of extracellular vesicles exposing tissue factor and citrullinated histone-3 in anti-neutrophil cytoplasmic antibody-associated vasculitides
title_sort augmented thrombin formation is related to circulating levels of extracellular vesicles exposing tissue factor and citrullinated histone-3 in anti-neutrophil cytoplasmic antibody-associated vasculitides
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616855/
https://www.ncbi.nlm.nih.gov/pubmed/37915326
http://dx.doi.org/10.3389/fmed.2023.1240325
work_keys_str_mv AT jonasdottirastadogg augmentedthrombinformationisrelatedtocirculatinglevelsofextracellularvesiclesexposingtissuefactorandcitrullinatedhistone3inantineutrophilcytoplasmicantibodyassociatedvasculitides
AT manojlovicmilena augmentedthrombinformationisrelatedtocirculatinglevelsofextracellularvesiclesexposingtissuefactorandcitrullinatedhistone3inantineutrophilcytoplasmicantibodyassociatedvasculitides
AT vojinovicjelena augmentedthrombinformationisrelatedtocirculatinglevelsofextracellularvesiclesexposingtissuefactorandcitrullinatedhistone3inantineutrophilcytoplasmicantibodyassociatedvasculitides
AT nordinannica augmentedthrombinformationisrelatedtocirculatinglevelsofextracellularvesiclesexposingtissuefactorandcitrullinatedhistone3inantineutrophilcytoplasmicantibodyassociatedvasculitides
AT bruchfeldannette augmentedthrombinformationisrelatedtocirculatinglevelsofextracellularvesiclesexposingtissuefactorandcitrullinatedhistone3inantineutrophilcytoplasmicantibodyassociatedvasculitides
AT gunnarssoniva augmentedthrombinformationisrelatedtocirculatinglevelsofextracellularvesiclesexposingtissuefactorandcitrullinatedhistone3inantineutrophilcytoplasmicantibodyassociatedvasculitides
AT mobarrezfariborz augmentedthrombinformationisrelatedtocirculatinglevelsofextracellularvesiclesexposingtissuefactorandcitrullinatedhistone3inantineutrophilcytoplasmicantibodyassociatedvasculitides
AT antovicaleksandra augmentedthrombinformationisrelatedtocirculatinglevelsofextracellularvesiclesexposingtissuefactorandcitrullinatedhistone3inantineutrophilcytoplasmicantibodyassociatedvasculitides